Journal profile · CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Science Translational Medicine
ISSN 1946-6234 · American Association for the Advancement of Science · UNITED STATES · Weekly · Founded 2009
Science Translational Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 15.55; subscription journal; median 334 days to acceptance (105 articles, last 24 months); community-reported acceptance: hard; 336 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Science Translational Medicine is published by American Association for the Advancement of Science and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, CAR-T cell therapy research and Immunotherapy and Immune Responses, together about 24.3% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine.
From the journal's Aims & Scope
Research area (LetPub): CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology9.4%
- CAR-T cell therapy researchMedicine7.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology7.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology7%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.4%
- Cancer Immunotherapy and BiomarkersMedicine4.4%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.1%
- Immune cells in cancerImmunology and Microbiology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CrossRef, CLOCKSS, HINARI, AGORA, OARE, CHORUS, COUNTERPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 15.55LetPub ·
- CiteScore 2026-06
- 25.6LetPub ·
- SJR 2026-06
- 7.03LetPub ·
- SNIP 2026-06
- 2.95LetPub ·
- h-index
- 168LetPub ·
- h-index
- 370OpenAlex ·
- i10-index
- 4,089OpenAlex ·
- 2-year mean citedness
- 15.78OpenAlex ·
- Self-citation rate
- 0.6%LetPub ·
- Share of gold OA articles
- 4.66%LetPub ·
Volume
- Articles per year
- 318LetPub ·
Articles by year OpenAlex count · 7,348 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 267 | 71 | 421 |
| 2025 | 336 | 153 | 4,118 |
| 2024 | 303 | 161 | 9,755 |
| 2023 | 290 | 181 | 14,034 |
| 2022 | 339 | 228 | 24,913 |
| 2021 | 376 | 237 | 34,992 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
334 daysMedian, submission to acceptance · P25–P75 212 days – 427 days
- Acceptance to online
- median 29 days (105 articles)
- Submission to online
- median 364 days
- Sample
- 105 articles with submission and acceptance dates (684 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- HardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- research articleResearch Article16 Sep 2026Length not stated
- reviewReviews 29 Jul 2026Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- American Association for the Advancement of Science
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Weekly
- Founded
- 2009
- ISSN
- 1946-6234
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Science Translational Medicine
What CAS zone is Science Translational Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Science Translational Medicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Cell Biology / Medicine, Research & Experimental; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Science Translational Medicine?
The latest impact factor listed by LetPub is 15.55; CiteScore 25.6, h-index 370.
How long does peer review take at Science Translational Medicine?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 334 days (interquartile range 212–427 days); authors report an average review time of about 1 month; the community-reported acceptance is “Hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Science Translational Medicine?
According to LetPub and DOAJ records, Science Translational Medicine is indexed in SCIE and Scopus.
Is Science Translational Medicine open access, and what is the APC?
Science Translational Medicine is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .